Home > Riviste > Minerva Urologica e Nefrologica > Fascicoli precedenti > Minerva Urologica e Nefrologica 2015 Dicembre;67(4) > Minerva Urologica e Nefrologica 2015 Dicembre;67(4):303-15

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA UROLOGICA E NEFROLOGICA

Rivista di Nefrologia e Urologia


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

REVIEWS  ADVANCED TOPICS IN THE TREATMENT OF LARGE RENAL STONES


Minerva Urologica e Nefrologica 2015 Dicembre;67(4):303-15

lingua: Inglese

Safety of percutaneous nephrolithotomy in patients on antithrombotic therapy: a review of guidelines and recommendations

Siev M. 1, Motamedinia P. 1, Leavitt D. A. 1, Keheila M. 1, Kiewe R. 2, Okeke Z. 1

1 The Arthur Smith Institute for Urology, Hofstra North Shore, Long Island Jewish School of Medicine, New Hyde Park, NY, USA;
2 Department of Cardiology, Hofstra North Shore, Long Island Jewish School of Medicine, New Hyde Park, NY, USA


PDF  


With the expanding use of chronic antithrombotic medical management for coronary artery disease, surgeons face the growing challenge of balancing the risks of postoperative bleeding against perioperative cardiovascular events. Percutaneous nephrolithotomy (PCNL) carries a risk of bleeding and the need for transfusion at baseline, which is further increased in patients on anticoagulation and antiplatelet therapy. Broad perioperative recommendations for risk stratification and antithrombotic management exist for surgical patients, however, they are less clear in those undergoing PCNL. In this review we appraise available literature, guidelines and opinions and present a consensus statement for antithrombotic management in patients undergoing PCNL.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

zokeke@nshs.edu